The QualityStocks Daily Wednesday, May 14th, 2025

Today's Top 3 Investment Newsletters

Top Pros' Top Picks(SEPN) $10.1600 +50.97%

Premium Stock Alerts(HWH) $1.7800 +47.11%

360 Wall Street(LUCY) $2.9000 +46.46%

The QualityStocks Daily Stock List

Leatt (LEAT)

QualityStocks, StockEarnings, MarketBeat, TopPennyStockMovers, Trades Of The Day, StocksEarning, SmallCapVoice and Nebula Stocks reported earlier on Leatt (LEAT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Leatt Corp (OTCQB: LEAT) is a company focused on designing, developing, marketing and dis-tributing personal protective equipment for participants of motor sports and leisure activities globally.

The firm has its headquarters in Durbanville, South Africa and was incorporated in 2001 by Christopher James Leatt. Prior to its name change in May 2005, the firm was known as Tread-zone Inc. It operates as part of the leisure industry, under the consumer cyclical sector. The firm serves consumers across the globe.

The enterprise’s offerings include Leatt-Brace system, an injection molded neck protection sys-tem designed to prevent injuries to the cervical spine and neck. It also offers helmets for head and brain protection; and body armor products, including full upper body protectors, chest pro-tectors, upper body protection vests, knee braces, back protectors, knee and elbow guards, impact shorts and cooling vests, off-road motorcycle boots, and mountain biking shoes. In addition to this, the enterprise provides other products, parts, and accessories, such as goggles; toolbelt, duf-fel, gear, helmet, and hydration bags; casual clothing and caps; hats; and apparels that comprises suits, jackets, jerseys, pants, shorts, socks, and gloves, as well as aftermarket support products. Further, it acts as the original equipment manufacturer for neck braces sold by other brands. The enterprise’s products are used by riders of motorcycles, bicycles, snowmobiles, and ATVs, as well as motor racing cars and other helmeted sports. It sells its products to consumers through its online store at leatt.com, as well as through a network of distributors and retailers.

Leatt (LEAT), closed Wednesday's trading session at $8.6, up 37.545%, on 19,512 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $5.01/$9.5.

Nutex Health (NUTX)

QualityStocks, The Online Investor, MarketBeat, Prism MarketView, Investment News Daily, InsiderTrades and 360wallstreet reported earlier on Nutex Health (NUTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nutex Health Inc. (NASDAQ: NUTX) is a technology-enabled healthcare services firm that is engaged in the provision of healthcare services.

The firm has its headquarters in Houston, Texas and was incorporated in 2011. It operates as part of the health information services industry, under the healthcare sector. The firm serves consum-ers around the globe, with a primary focus on those in the United States.

The enterprise operates through the Population health management division and the Hospital di-vision. The Hospital division is involved in operating and owning about 21 facilities which are located in 8 different states. This division is also involved in the operation and implementation of various health care models, including specialty hospitals, micro-hospitals and hospital outpatient departments. On the other hand, the Population health management segment is involved in the operation and owning of provider networks like IPAs (Independent Physician Associations). This division’s cloud-based proprietary technology platform also aggregates data across a range of in-formation systems, sources and settings to create a holistic view of each provider and patients, while also facilitating care delivery. The enterprise’s Management Services Organizations offer administrative, management, and other support services to its affiliated physician groups and hospitals.

Nutex Health (NUTX), closed Wednesday's trading session at $158.8, up 26.1018%, on 484,910 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $4.16/$182.

NetSol Technologies (NTWK)

Wall Street Resources, QualityStocks, Greenbackers, TaglichBrothers, Momentum Traders, InvestorPlace, StockEgg, OTCJournal, 777 Stocks, SeriousTraders, StockOodles, MarketBeat, HotOTC, The Street, CoolPennyStocks, StockMarketWatch, StockEarnings, BullRally, Stocktwiter, Hit and Run Candle Sticks, Penny Invest, Zacks, PennyStockVille, PennyTrader Publisher, Access Wallstreet, MadPennyStocks, RedChip, PennyInvest, FeedBlitz, The Momentum Traders Network, StockRich, Breaking Bulls, MicrocapVoice, Marketbeat.com, OTCtipReporter, CRWEPicks, Stock Fortune Teller, PennyStockScholar, StreetInsider, StreetAuthority Daily, GorillaTrades, TipRanks, DrStockPick, CRWEWallStreet, PennyOmega, CRWEFinance, StocksEarning, TradersPro, BUYINS.NET, Trading Concepts, Trading Markets, UrPicks, Top Online Stocks, Investing Futures, Penny Stock Rumble, M2 Communications, Mad Stock Pic, Stockhouse, StockHotTips, Stock Rich, MarketClub Analysis, SmallCapVoice, OTC Journal, Red Chip, OTCPicks, OTCReporter, PennyToBuck and StockSpice reported earlier on NetSol Technologies (NTWK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Netsol Technologies Inc. (NASDAQ: NTWK) (FRA: NS9B) is a company focused on designing, developing, marketing and exporting enterprise software solutions to the banking, automobile financing and leasing, and financial services industries globally.

The firm has its headquarters in Calabasas, California and was incorporated in 1995 by Salim Ullah Ghauri. It operates as part of the software-application industry, under the technology sector. The firm serves consumers around the globe.

The enterprise’s offerings include a suite of financial applications for businesses in the finance and leasing industry dubbed NFS Ascent. Its NFS Ascent constituent applica-tions include a web-based application known as Omni Point of Sale; a web-based so-lution that could be used in conjunction with WFS or any third-party wholesale fi-nance system dubbed the Dealer Auditor Access System; an application for managing and maintaining credit contracts known as the Contract Management System (CMS); and a system for automating and managing the lifecycle of wholesale finance dubbed the Wholesale Finance System. The enterprise also offers a white label platform, which includes Dealer/Admin Tool and Customer Portals dubbed the Otoz Platform; an API-based architecture known as the Otoz Ecosystem; and Otoz Digital Auto-Retail, a white-label SaaS platform. This is in addition to offering system integration, consulting, and information technology products and services. It serves Dow-Jones 30 Industrials, blue chip organizations, vehicle manufacturers, Fortune 500 manufacturers and financial institutions.

NetSol Technologies (NTWK), closed Wednesday's trading session at $2.81, up 12.4%, on 151,706 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $2.14/$3.34.

Gatekeeper Systems (GKPRF)

InvestorPlace, QualityStocks and Trades Of The Day reported earlier on Gatekeeper Systems (GKPRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Gatekeeper Systems Inc. (OTC: GKPRF) (CVE: GSI) (FRA: 1GK) is a company focused on designing, manufacturing, marketing and selling video security solutions for extreme and mo-bile environments.

The firm has its headquarters in Abbotsford, Canada and was incorporated in 1997 by Doug-las A. Dyment. It operates as part of the security and protection services industry, under the industrials sector. The firm primarily serves consumers in Canada and the United States.

The enterprise’s offerings include the AI Dash Cam, an AI-based dash cam that offers driver status monitoring and advanced driver assistance systems; G4 Viewer, which revolutionizes video management for fleet monitoring; and CLARITY, an integrated video and passenger counting school bus operating platform. It also offers Automated Lane Enforcement, a video and data analytics solution that provides automatic enforcement of transit lane violations; in-terior and exterior cameras, and mobile data collectors; and wireless systems, such as access points, yard guards, mobile wireless modules, and mobile Wi-Fi systems. This is in addition to providing a health monitoring panel that measures the body temperature of individuals enter-ing a transportation vehicle or building; a school bus student protector solution that automati-cally enforces stop-arm violations; and an intelligent temperature sensing system. Further, the enterprise offers on-site system maintenance and repair, testing, troubleshooting, system in-stallation, training, and warranty support services. It serves the transit, school bus, police, am-bulance, taxi, and transport markets.

Gatekeeper Systems (GKPRF), closed Wednesday's trading session at $0.37, up 12.1212%, on 349,769 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $0.2128/$0.55.

Petros Pharmaceuticals (PTPI)

MarketClub Analysis, QualityStocks, INO Market Report, Premium Stock Alerts, Broad Street, Trades Of The Day, The Online Investor, MarketBeat, InvestorsUnderground and 247 Market News reported earlier on Petros Pharmaceuticals (PTPI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Petros Pharmaceuticals Inc. (NASDAQ: PTPI) is a pharmaceutical firm that is focused on the ac-quisition, development and commercialization of therapeutics for men’s health issues.

The firm has its headquarters in New York and was incorporated in 2020, on May 14th. It operates as part of the pharmaceutical and medicine manufacturing industry, under the health care sector. The firm serves consumers around the globe.

The company is focused on therapies which promote the preservation, tolerability and medication adherence of male organic function as an interdependent and integrated spectrum. It operates via its medical devices, and the prescription medications segments. The devices segment is comprised of vacuum erection devices while the prescription segment handles the company’s patented formula-tions.

The enterprise’s product portfolio is comprised of its new and patented topical candidate dubbed H100, which has been developed to treat acute Peyronie’s disease. The enterprise also develops its PDE-5 inhibitor prescription drug known as Stendra, which has been developed to treat erectile dysfunction. Stendra is the sole patent-protected PDE-5 inhibitor on the market which has been approved by the FDA for use. The enterprise markets its line of vacuum erection device products through Timm Medical Inc., its subsidiary.

Petros Pharmaceuticals (PTPI), closed Wednesday's trading session at $0.14, up 10.4101%, on 34,656,824 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $0.101/$18.

LogicMark Inc. (LGMK)

Premium Stock Alerts, QualityStocks, StockEarnings, Cabot Wealth, The Online Investor, Penny Stock, Money Wealth Matters, InsiderTrades, Early Bird, 360wallstreet and 247 Market News reported earlier on LogicMark Inc. (LGMK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

LogicMark Inc. (NASDAQ: LGMK) (FRA: 0NIA) (LON: 0KA8) is engaged in the provision of personal emergency response systems, Internet-of-Things technology and health communications devices which create a connected care platform.

The firm has its headquarters in Louisville, Kentucky and was incorporated in 2012, on February 8th by David Charles Tunnell and Gino Miguel Pereira. Prior to its name change in March 2022, the firm was known as Nxt-ID Inc. It operates as part of the security and protection services industry, under the industrials sector. The firm serves consumers around the globe.

The company’s mission is to always apply the latest technologies for improved and new personal emergency response systems to help its consumers enjoy much-deserved independence. It operates through one business segment, called the software and hardware security systems and applications. The company continues to revolutionize the personal emergency response system industry by developing a 2-way voice com-munication technology that’s directly connected to the medical alert pendant, which improves the quality of life of its wearers significantly.

The enterprise, which operates through its LogicMark LLC subsidiary, manufactures and distributes monitored and non-monitored personal emergency response systems which are sold via monitored security distributors/dealers, healthcare durable medical equipment distributors and the U.S. Department of Veterans Affairs.

LogicMark Inc. (LGMK), closed Wednesday's trading session at $0.015, up 10.2941%, on 210,658,051 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $0.007/$24.

Monopar Therapeutics (MNPR)

StreetInsider, QualityStocks, MarketBeat, MarketClub Analysis, The Stock Dork, Prince Report, Timothy Sykes, The Online Investor, stockstotrade, StockMarketWatch, Financial Newsletter, Early Bird and 360 Wall Street reported earlier on Monopar Therapeutics (MNPR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Monopar Therapeutics Inc. (NASDAQ: MNPR) (FRA: 1IY) is a clinical-stage biopharmaceutical firm that is focused on the development of proprietary therapeutics to improve clinical outcomes for cancer patients.

The firm has its headquarters in Wilmette, Illinois and was incorporated in December 2014, by Andrew P. Mazar, Christopher M. Starr and Chandler D. Robinson. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm has two companies in its corporate family and serves consumers in the United States.

The company is party to a collaboration agreement with the Cancer Science Institute of Singa-pore, which entails evaluating MNPR-202 activity and related analogs in various types of cancer. It is also party to a collaboration with NorthStar Medical Radioisotopes LLC, for the develop-ment of radio-immuno-therapeutics which target severe coronavirus infections; and another with Grupo Español de Investigaciónen Sarcomas, to develop camsirubicin for patients with advanced soft tissue sarcoma.

The enterprise’s product portfolio is made up of a topoisomerase II-alpha targeted doxorubicin analog known as Camsirubicin, which has been designed to retain anti-cancer activity and mini-mize the toxic effects of therapies on patients’ hearts; and a clonidine mucobuccal tablet dubbed Validive, which is undergoing a phase 2 trial testing its efficacy in treating radiation induced se-vere oral mucositis in patients with oropharyngeal cancer. It also develops a humanized monoclo-nal antibody dubbed MNPR-101, to treat advanced cancers and preclinical stage severe corona-virus infections.

Monopar Therapeutics (MNPR), closed Wednesday's trading session at $37.11, up 9.728%, on 16,831 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $1.719/$54.3.

Impact BioMedical (IBO)

MarketClub Analysis, Premium Stock Alerts and QualityStocks reported earlier on Impact BioMedical (IBO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Impact BioMedical Inc. (NYSE American: IBO) is a biotechnology company focused on discov-ering, developing, and commercializing products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, con-sumer healthcare, and wellness products.

The firm has its headquarters in Houston, Texas and was incorporated in 2018, on October 16th. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe, with a focus on those in the United States.

Impact BioMedical discovers, confirms, and patents science and technologies, which can be de-veloped into new offerings in biopharmaceuticals and consumer healthcare and wellness in col-laboration with external partners through research, licensing, co-development, joint ventures, and other relationships.

The enterprise’s offerings include Laetose technology, which is derived from a unique combina-tion of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone; and Linebacker, a platform of small molecule electrophilically enhanced polyphenol com-pounds with application in oncology, inflammatory disorders, and neurology. Impact BioMedical also develops functional fragrance formulation, a suite of functional fragrances containing spe-cialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the enterprise develops Equivir/Equivir G technology, a novel blend of polyphenols which have demonstrated antiviral effects for use as health supplements and medications.

Impact BioMedical (IBO), closed Wednesday's trading session at $0.5205, off by 5.2258%, on 486,160 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $0.37/$6.17.

Tonix Pharmaceuticals (TNXP)

QualityStocks, InvestorBrandNetwork, BioMedWire, SeriousTraders, SmallCapRelations, Stocks to Buy Now, StockMarketWatch, NetworkNewsWire, MissionIR, StocksToBuyNow, TinyGems, SmallCapSociety, Tip.Us, MarketClub Analysis, Premium Stock Alerts, BUYINS.NET, MarketBeat, TraderPower, InvestorPlace, PennyStockLocks, The Online Investor, StockRockandRoll, StreetInsider, 360 Wall Street, Penny Stock 101, Marketbeat.com, Barchart, RedChip, Daily Trade Alert, INO.com Market Report, OTCtipReporter, Buzz Stocks, Penny Pick Finders, HotOTC, StockOnion, PennyStockProphet, Trades Of The Day, TopPennyStockMovers, Streetwise Reports, Profitable Trader Authority, Street Insider, Wealth Insider Alert, The Street, Early Bird, Fanchon Sweet, FeedBlitz, StockReport, Investing Futures, plrinvest, Small Cap Firm, Penny Stock 103, InvestorsUnderground, Jason Bond, Schaeffer's, Promotion Stock Secrets, MarketWatch, Prism MarketView, Weekly Wizards, neupretpurireae6, Penny Stock 109 and Investment House reported earlier on Tonix Pharmaceuticals (TNXP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tonix Pharmaceuticals (NASDAQ: TNXP) has appointed Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations. Hand brings decades of leadership experience across legal, HR, and corporate services, including a pivotal role in Celgene’s $74 billion acquisition by Bristol Myers Squibb and the $13.4 billion divestiture of Otezla® to Amgen. His addition comes as Tonix prepares for a potential launch of TNX-102 SL for fibromyalgia, pending FDA approval.

To view the full press release, visit https://ibn.fm/7BKOa

About Tonix Pharmaceuticals Holding Corp.

Tonix is a fully integrated biopharmaceutical company focused on transforming therapies for pain management and modernizing solutions for public health challenges. Tonix’s priority is to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) this month for TNX-102 SL, a product candidate for which two statistically significant phase 3 studies have been completed for the management of fibromyalgia. TNX-102 SL was generally well tolerated in the phase 3 program. The FDA has granted Fast Track designation to TNX-102 SL for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction. Tonix recently announced that the U.S. Department of Defense (“DoD”), Defense Threat Reduction Agency (“DTRA”) awarded it a contract for up to $34 million over five years to develop TNX-4200, small molecule broad-spectrum antiviral agents targeting CD45 for the prevention or treatment of infections to improve the medical readiness of military personnel in biological threat environments. Tonix owns and operates a state-of-the art infectious disease research facility in Frederick, Maryland. The company’s Good Manufacturing Practice (“GMP”)-capable advanced manufacturing facility in Dartmouth, Maryland, was purpose-built to manufacture TNX-801, and the GMP suites are ready to be reactivated in case of a national or international emergency. Tonix’s development portfolio is focused on central nervous system (“CNS”) disorders. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase), a biologic in Phase 2 development designed to treat cocaine intoxication that has Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R)(sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. For more information about the company, please visit www.TonixPharma.com .

Tonix Pharmaceuticals (TNXP), closed Wednesday's trading session at $22.08, up 9.4153%, on 945,850 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $6.76/$672.

Knightscope (KSCP)

QualityStocks, InvestorBrandNetwork, MissionIR, SeriousTraders, SmallCapRelations, Stocks to Buy Now, ESGWireNews, Tip.us, StocksToBuyNow, AINewsWire, SmallCapSociety, TinyGems, TechMediaWire, NetworkNewsWire, MarketBeat, Jeff Bishop, 360 Wall Street, Broad Street, Fierce Analyst, InvestorPlace, InvestorsUnderground, MarketMovingTrends, Trading with Manny, Tiny Gems, The Daily Market Alert, Smart Investing Society, StockWireNews and MarketClub Analysis reported earlier on Knightscope (KSCP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Knightscope (NASDAQ: KSCP) reported Q1 2025 revenue of $2.9 million, up 29% year-over-year, while net loss narrowed to $6.9 million, a 19% improvement. The company improved gross margin loss to (23%) from (64%) and cut G&A expenses by 24%. Knightscope ended the quarter with $12.7 million in cash and a $2.5 million backlog. Strategic initiatives included securing a 33,000-square-foot headquarters in Sunnyvale, California, and raising $8.8 million in equity offerings. The company will present at the Ladenburg Thalmann Innovation EXPO25 on May 21 in New York.

To view the full press release, visit https://ibn.fm/vt4qv

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com .

Knightscope (KSCP), closed Wednesday's trading session at $5.71, up 8.3491%, on 470,336 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $2.45/$28.5712.

Verano Holdings Corp. (VRNOF)

QualityStocks, CannabisNewsWire, MarketBeat, InvestorPlace, The Street, Earnings360, Early Bird and Cabot Wealth reported earlier on Verano Holdings Corp. (VRNOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

New York Governor Kathy Hochul signed the state’s latest budget into law on Friday, but one key proposal that had stirred significant backlash didn’t make it into the final version. Earlier this year, Hochul had proposed allowing police to use the smell of cannabis as a reason to suspect a driver of being under the influence and require them to undergo a drug test.

Lawmakers removed the clause after strong opposition from dozens of advocacy groups. In a letter sent to Hochul and state leaders, over 60 reform organizations warned that such a policy would revive harmful tactics from the drug war and open the door to racial profiling by police. Critics argued it would reverse the progress made since cannabis legalization, especially in a state with a troubling history of unequal enforcement.

The proposed change didn’t just face pushback from advocacy groups—it also raised concerns among political leaders, including the state Assembly’s majority leader and the director of the state’s Office of Cannabis Management, Tremaine Wright. Both emphasized that the plan was out of step with the intent of legalization and wouldn’t be effective for New York.

New York has long struggled with racial disparities in drug enforcement. During the 2010s, for instance, Black residents in NYC were arrested for marijuana possession at a rate over nine times higher than white residents.

In terms of other marijuana-related updates in the new budget, there’s a notable change involving the state’s Cannabis Control Board (CCB). The $229,000 annual salary for the board’s chair has been eliminated. Despite the pay cut, current chair Tremaine Wright said she plans to stay in the role. Speaking at an industry event in Albany, she noted that she accepted the position before knowing the compensation and that her commitment wasn’t based on salary.

Wright also clarified that the decision to eliminate the salary wasn’t due to any conflict. She described the evolving nature of the cannabis industry and emphasized that the board, like license holders and applicants, needs to adapt to changes as they come.

A spokesperson for Governor Hochul explained that most state board chairs serve without pay, and this change simply brings the CCB in line with other boards. In addition, the signed bill allocates $5 million to the OCM to hire more enforcement staff, signaling a push to strengthen oversight as the state’s legal cannabis market grows.

The entire marijuana industry around the country, including major firms like Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), will be relieved that the provision allowing police to use cannabis smell as probable cause to subject drivers to searches and drug tests in New York was struck out by lawmakers since it could set an unwelcome precedent for other jurisdictions.

Verano Holdings Corp. (VRNOF), closed Wednesday's trading session at $0.727742, up 2.4989%, on 131,266 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $0.41/$5.95.

SurgePays (SURG)

Wall Street Resources, SmarTrend Newsletters, SmallCapVoice, StockRockandRoll, MoneyTV, PennyStockLocks, QualityStocks, InvestorPlace, StreetInsider, Penny Stock 101, INO.com Market Report, Penny Stock General, OTCPicks, Early Bird, The Street, Greenbackers, Shiznit Stocks, MassiveStockProfits, BestOtc, DrStockPick, CRWEWallStreet, CRWEPicks, CRWEFinance, PennyOmega, StockHotTips, PennyToBuck, StockOodles, Stockhouse, Zacks, AllPennyStocks, Barchart, Wall Street Daily, ChartAdvisor, The Night Owl, Street Insider, StockOnion, Penny Stock 118, Real Pennies, MarketBeat, MarketClub Analysis, Premium Stock Alerts, Mega Stock Alerts, PennyTrader, OTCtipReporter, PennyStockScholar, Penny Stock 112, 360 Wall Street and Small Cap Firm reported earlier on SurgePays (SURG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SurgePays (Nasdaq: SURG) has entered into a $7 million senior secured convertible note agreement with a current institutional shareholder, providing $6 million in cash and involving a repurchase of 333,333 shares. The two-year note is convertible into common stock at $4.00 per share, a premium to current market price, and includes a prepayment option at a 2% premium. Proceeds will support the national launch of LinkUp Mobile and the growth of SurgePays’ MVNE wholesale platform following its April 1 integration with AT&T. Management projects over $200 million in revenue and positive cash flow from operations by year-end 2025.

To view the full press release, visit https://ibn.fm/Fae3M

About SurgePays, Inc.

SurgePays, Inc. is a wireless and fintech company focused on delivering mobile connectivity and financial services to underserved communities. As both a mobile virtual network operator (“MVNO”) and mobile virtual network enabler (MVNE), SurgePays operates its own wireless brand while also providing back-end infrastructure, including provisioning and billing, to other wireless providers. The Company’s proprietary point-of-sale platform is used nationwide in thousands of retail locations, enabling SIM activations, top-ups, and digital financial services. SurgePays is built to scale and uniquely positioned to grow across both retail and wholesale wireless channels.

For more information, visit the company’s website at: https://surgepays.com/

SurgePays (SURG), closed Wednesday's trading session at $2.53, off by 24.7024%, on 909,537 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $1.0486/$4.38.

The QualityStocks Company Corner

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) is nearing the commissioning of its RapidSX(TM) Commercial Demonstration Plant in Kingston, Ontario, a key milestone in its plan to commercialize its advanced rare earth element (REE) separation technology. The company is also preparing to construct its first Strategic Metals Complex (SMC) in Louisiana, expected to process 2,000 tons of total rare earth oxides by the end of 2024 and scale to 5,000 tons in 2026. Ucore's long-term roadmap includes additional SMCs in Alaska and Canada, alongside the development of its 100%-owned Bokan-Dotson Ridge HREE resource in Alaska. With strong U.S. and Canadian government support and partnerships with Kingston Process Metallurgy and Mech-Chem Associates, Ucore aims to establish a complete North American REE supply chain independent of China.

To view the full press release, visit https://ibn.fm/5kLDa

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) is a critical metals (“CM”) separation technology company executing an ESG-centered plan toward establishing a comprehensive North American critical metals supply chain. The company has developed a transformative commercial-ready technology, RapidSX™, for separating and purifying critical metals. Ucore intends to deploy this technology in pursuit of a CM supply chain independent of China for Western original equipment manufacturers (“OEMs”), most notably in the automotive and renewable energy industries.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. Its initial focus is on processing heavy and light rare earth elements (“REEs”), disrupting a supply chain that is dominated by China.

China currently controls about 80% of the world’s access to REE mining projects and over 90% of the world’s REE processing capabilities, and it produces about 95% of the goods containing REE components.

Ucore is working to scale Western supply needs by establishing REE separation and rare earth oxide (“REO”) production capabilities in cooperation with strategic upstream supply and downstream offtake partnerships. The company, along with its industry partners, aims to unlock access to Western REEs for current consumer, energy, manufacturing and military sectors.

By 2025, Ucore expects to commercially separate U.S.-friendly sources of REEs and supply OEMs with REOs required to produce rare earth permanent magnets (“REPMs”) – the essential component of electric motors and generators required to support the world’s transition to electrification and sustainable energy sources.

The company intends to contribute to this initiative through the near-term development of a heavy and light rare-earth processing facility in Louisiana and subsequent development of Strategic Metals Complexes (SMCs) in Alaska and Canada, as well as through the longer-term development of its 100%-owned Heavy Rare Earth Element (HREE) mineral resource property at Bokan Mountain on Prince of Wales Island, Alaska.

Ucore is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Demonstration Plant

The Kingston, Ontario, RapidSX™ Demonstration Plant commissioning process is underway. Once commissioned, the plant is designed to demonstrate the commercial capabilities of the RapidSX technology platform.

The RapidSX demo plant will show:

  • The techno-economic advantages of the RapidSX technology platform
  • The processing of tens of tons of heavy and light mixed rare earth element concentrates in a simulated production environment
  • The platform’s ability to operate for thousands of semi-continuous run-time hours
  • Production of high-purity NdPr, praseodymium, neodymium, terbium and dysprosium rare earth elements for early OEM product qualification trials

The demo plant is located within Ucore’s 5,000-square-foot RapidSX Commercialization and Demonstration Facility and is run by its laboratory partner, Kingston Process Metallurgy Inc. (“KPM”).

RapidSX™ Technology

Innovation Metals Corp., acquired by the company in 2020, developed the RapidSX separation technology platform with early-stage assistance from the United States Department of Defense, later resulting in the production of commercial-grade, separated rare earth elements at pilot scale.

RapidSX combines the time-proven chemistry of conventional solvent extraction (SX) with a new column-based platform that significantly reduces time to completion and plant footprint, as well as potentially lowering capital and operating costs. SX is the international REE industry’s standard commercial separation technology and is currently used by all REE producers worldwide for bulk commercial separation of both heavy and light REEs.

Utilizing similar chemistry to conventional SX, RapidSX is not a “new” technology, but it represents a significant improvement on the well-established, well-understood, proven conventional SX separation technology preferred by REE producers.

Strategic Metals Complex

Ucore, engineering partner Mech-Chem Associates Inc. and KPM are developing the full-scale engineering for the company’s first Strategic Metals Complex (SMC). The SMC is a planned REE separation and rare earth oxide production plant slated to commence construction in Louisiana in 2023. It is scheduled to initially process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.

The company has three initial U.S.-friendly feedstock agreements in place for the Louisiana complex, along with multiple developing offtake agreements. It received a C$16 million+ incentive package offer from Louisiana Economic Development to support construction of the SMC.

Bokan-Dotson Ridge REE Deposit

Ucore has invested over C$35 million to establish and validate the Bokan-Dotson Ridge resource in preparation for mine design and permitting. Initial drilling is complete, and a Preliminary Economic Assessment has been issued. Next steps for the project include a feasibility study, detailed mine design and permit acquisition. The project can be “near shovel ready” for construction in less than 30 months after receipt of the next stage of development funding.

Market Opportunity

According to a report by Grand View Research, the global rare earth elements market was valued at $2.8 billion in 2018 and is forecast to reach a value of $5.6 billion by 2025, achieving a CAGR of 10.4% during the period. Market growth is driven by increasing demand for these elements in the manufacturing of magnets and catalysts for the automotive industry. Rising demand for electric vehicles to reduce CO2 emissions is expected to propel the use of permanent magnets in the production of EV batteries.

China is the major producer and consumer of REEs. To maintain self-sufficiency and to meet future demand, China has been raising the export tariffs on rare earth elements shipped to various countries, including the U.S., Japan, India, Brazil and the European Union. This led to the current supply-demand gap in these countries, as they rely on imports from China.

China reduced the exports of REEs by 72% in the second half of 2010 to preserve its reserves of these elements and continues to export REEs at reduced levels, thereby affecting industries such as automotive, oil and gas, and electronics, which require an ample amount of rare earth elements.

Management Team

Pat Ryan, P.Eng., is Chairman and CEO of Ucore Rare Metals. He began as a director with the company when he developed a heightened interest in critical metals. Before joining Ucore, he founded and led a multimillion-dollar automotive OEM design and lean manufacturing company. His understanding of complex supply chains across international markets has led to a prime positioning as the global auto industry transitions to vehicle electrification. He holds a Bachelor of Engineering degree from Dalhousie University.

Peter Manuel is Vice President and CFO of Ucore. Prior to joining the company, he practiced as a Chartered Accountant for more than 17 years, providing consulting services to companies in a range of industries, with a focus on the financial services and resource sectors. He spent 10 years in England and Ireland providing assurance, strategic planning, corporate finance and other consulting services to a portfolio of both public and private entities. He holds a Bachelor of Commerce Degree from Dalhousie University.

Michael Schrider, MEng, P.E., is Vice President and COO of Ucore. He is a multidisciplinary engineer who has been involved in manufacturing, engineering and managing complex structural and mechanical systems projects since 1989. He was the Founder, President and Chief Engineer of Schrider & Associates and Alton Bay Design, both engineering services firms. He holds a bachelor’s degree in naval architecture and marine engineering from the University of New Orleans and a master’s degree in mining, geological and geophysical engineering from the University of Arizona.

Mark MacDonald is Vice President of Investor Relations at Ucore. He has over 25 years of experience implementing award winning business development and marketing programs at regional and national levels. As Vice President of Sales, he was responsible for Mediapro Communication’s growth as AT&T Canada’s leading B2B sales partner. He subsequently became Atlantic Regional Vice President of AT&T Canada Corp. He holds a Bachelor of Commerce degree from Dalhousie University.

Investment Considerations
  • Ucore currently owns an REE mining project and an advanced separation technology.
  • Commercial demonstration of the company’s RapidSX™ technology is at the commissioning stage.
  • Ucore plans several modern REE refineries in North America, with the first SMC slated to begin construction in Louisiana in 2023. This planned REE separation and rare earth oxide production plant is scheduled to process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.
  • Through its strategic partnerships with Kingston Process Metallurgy Inc., Mech-Chem Associates Inc. and other supporting contractors and vendors, Ucore is developing a North American REE supply chain.

Ucore Rare Metals Inc. (UURAF), closed Wednesday's trading session at $1.14, up 2.6103%, on 324,564 volume. The average volume for the last 3 months is 242,930 and the stock's 52-week low/high is $0.33/$1.64.

Recent News

FAVO Capital Inc. (OTC: FAVO)

The QualityStocks Daily Newsletter would like to spotlight FAVO Capital Inc. (NASDAQ: FAVO).

FAVO Capital (OTC: FAVO) , a provider of revenue-based funding solutions for SMBs, announced its participation in the D. Boral Capital Inaugural Global Conference on May 14, 2025, at The Plaza Hotel in New York City. President Shaun Quin will represent the company in meetings with institutional investors, highlighting FAVO's growth strategy and IPO readiness. CEO Vincent Napolitano emphasized the event as a key platform to expand visibility and engage potential investors ahead of the company's planned uplisting.

To view the full press release, visit https://ibn.fm/TNW4T

FAVO Capital Inc. (OTC: FAVO) is redefining the private credit and alternative lending industry through a strategic redevelopment of its operations and offerings. With a focus on leveraging financial technology and a client-centric approach, FAVO Capital empowers small to medium-sized businesses with fast, flexible, and reliable access to capital, bridging the gap left by traditional financial institutions.

Empowering Businesses, Redefining Private Credit

As part of its strategy to uplist to Nasdaq, FAVO Capital is enhancing its technology platform, operational scalability, and market positioning to meet higher regulatory standards and attract institutional investors. Headquartered in Fort Lauderdale, Florida, FAVO employs over 120 professionals across five global offices, delivering sustainable growth and value for clients and shareholders alike.

Products and Services

  • Proprietary Lending Platform and Mobile App (In Development): FAVO Capital is in the early stages of developing an advanced digital platform designed to enhance client engagement and streamline funding processes. This platform will eventually allow businesses to apply for funding products, track progress, and manage repayment efficiencies. A complementary mobile app is also being planned to provide real-time insights and tailored recommendations, laying the groundwork for an improved borrower experience.
  • Fintech-Driven Lending Solutions: FAVO Capital is exploring proprietary and third-party technology tools, including advanced analytics and algorithms, to enhance decision-making speed and reliability in the lending process.
  • Flexible Financing Options: FAVO specializes in structuring customized capital solutions tailored to the diverse needs of small business owners, offering scalable and adaptable products that evolve with changing market conditions.

Market Opportunity

The private credit market is experiencing exponential growth as traditional banks reduce their focus on small business lending. According to industry reports, the global private credit market is projected to surpass $1.5 trillion by 2025, driven by increasing demand for alternative financing options.

FAVO Capital is uniquely positioned to capture market share within this booming sector by leveraging fintech innovation to meet the needs of underserved small businesses. With a focus on efficiency, speed, and client satisfaction, FAVO addresses critical gaps in the financial ecosystem while building a platform for long-term growth.

Recent Highlights

  • Fintech Innovation: Initial investments in app development and analytics lay the groundwork for future operational efficiency and improved borrower experience.
  • Operational Scale: A global footprint with over 120 employees combines the agility of a local lender with the reach of an international financial institution.
  • Proven Growth: FAVO’s technology-driven approach has enabled consistent expansion, solidifying its reputation as a trusted partner for small businesses.

Leadership Team

Vincent Napolitano is a Founder and CEO of FAVO Capital Inc. With over two decades of experience in finance and business development, Vincent has been instrumental in building FAVO Capital into a trusted partner for businesses seeking innovative financial strategies. Prior to founding FAVO Capital, Vincent spent 25 years on Wall Street, holding key positions at prominent firms and developing expertise in structuring complex financial deals. He also served as Chief Investment Officer for multiple special purpose vehicles (SPVs), acquiring private stock in pre-IPO unicorn companies such as Facebook and Twitter.

Shaun Quin is a Founding Member and President of FAVO Capital Inc., overseeing the company’s mission to deliver innovative and efficient private credit solutions to small and medium-sized businesses. With over 20 years of global experience as a partner, investor, and director, Shaun brings a strategic and customer-focused approach to his leadership. His expertise in fostering collaboration, building high-performance cultures, and empowering businesses has positioned FAVO Capital as a trusted leader in private lending.

Vaughan Korte, CFO, brings over 15 years of global financial expertise to his role with FAVO Capital Inc. His track record includes managing financial operations for Adidas across 60 countries with budgets exceeding $500 million. Vaughan’s leadership ensures FAVO Capital remains financially resilient, aligning financial strategy with organizational goals and fostering shareholder value.

Glen Steward, Chief Strategy Officer, is a seasoned entrepreneur with over 28 years of experience in the investment and trading industries. He drives FAVO Capital’s strategic initiatives, ensuring the company remains competitive and agile in a rapidly evolving market. Glen has held directorships and board memberships across Mauritius, South Africa, and the United States. His strategic acumen has been pivotal in integrating the FAVO Group of Companies into FAVO Capital Inc., fueling growth and market leadership.

Advisory Board

Bilal Adam, Accounting & Financial Counsel, is a financial expert with over 20 years of experience, including roles as CEO of Stewards Investment Capital. His insights into bespoke investment solutions, including fixed income, equity, and digital assets, support FAVO Capital’s innovative approach to private credit.

Honorable Earnest Hart, Corporate Governance Counsel, brings decades of legal and governance experience, having served as a New York Supreme Court Judge and COO at Columbia University Medical Center. His guidance ensures FAVO Capital maintains robust corporate governance standards.

Rocco Trotta, Business Leadership and Scalability Counsel, is the co-founder of LiRo-Hill and has decades of experience scaling businesses. His expertise in organizational efficiency and talent development strengthens FAVO Capital’s ability to attract excellence across all aspects of the business.

As FAVO Capital redevelops its operations and prepares for an uplisting to Nasdaq, the company is laying the foundation to redefine private credit with emerging fintech solutions and exceptional leadership. Learn more by visiting investors.favocap.com.

Investment Considerations
  • Early-Stage Technology Development: Laying the groundwork for proprietary platforms and scalable digital tools.
  • Significant Market Opportunity: The private credit market is projected to exceed $1.5 trillion by 2025, providing exponential growth potential.
  • Scalable Business Model: Automated processes and data-driven decision-making enable rapid scaling with minimal overhead.
  • Customer-Centric Approach: FAVO’s focus on small businesses and flexible financing solutions addresses critical gaps in the financial ecosystem.
  • Experienced Leadership: A forward-thinking executive team ensures strategic growth and innovation.

FAVO Capital Inc. (OTC: FAVO), closed Wednesday's trading session at $1.05, up 2.9412%, on 200 volume. The average volume for the last 3 months is 130 and the stock's 52-week low/high is $0.162/$1.45.

Recent News

ONAR Holding Corp. (OTCQB: ONAR)

The QualityStocks Daily Newsletter would like to spotlight ONAR Holding Corp. (OTCQB: ONAR).

The AI marketing market is projected to surge to more than $107.5 billion by 2028

ONAR Holding recently announced the launch of ONAR Labs, its dedicated technology incubator

The company also unveiled its first product offering: Cortex, an AI-powered marketing intelligence platform

Artificial intelligence ("AI") is rapidly transforming the marketing landscape, enabling businesses to deliver more personalized, efficient and data-driven campaigns. As companies seek to harness the power of AI to stay competitive, ONAR Holding Corp. (OTCQB: ONAR) is at the forefront with its innovative Cortex platform, poised to redefine the future of advertising.

ONAR Holding Corp. (OTCQB: ONAR) is a leading marketing technology company and marketing agency network focused on delivering integrated, AI-driven solutions to accelerate revenue growth for its clients. Through an agile agency network specializing in performance marketing, full-service healthcare marketing, experiential marketing, and technology incubation, ONAR provides best-in-class services to a growing roster of clients worldwide.

Built on a foundation of innovation and operational excellence, ONAR’s vision is to redefine marketing services by leading with technological advancement. With employees across five continents, the company is aggressively expanding its team to support both organic growth and an active acquisition pipeline. ONAR’s strategic growth model focuses on growing and acquiring proven agencies under one umbrella to deliver superior service offerings across industries.

ONAR’s mission is to drive measurable client success through integrated, high-impact marketing solutions that blend creativity, data science, and technology. As it continues to expand, ONAR is focused on building a global marketing services network that serves companies ranging from $10 million to $300 million in revenue.

The company is headquartered in Miami, Florida.

Portfolio

ONAR’s operations are organized across a network of specialized agencies that together serve more than 45 clients across a wide range of industries. Each agency brings deep domain expertise and a results-driven approach:

  • Storia: A premier performance marketing agency specializing in brand growth, paid media, and SEO. With a focus on data-driven excellence, Storia delivers highly targeted marketing strategies that maximize ROI across digital platforms. The agency partners with leading brands to drive measurable revenue outcomes and long-term brand equity.
  • Of Kos: A full-service healthcare marketing agency committed to redefining the patient experience. Of Kos partners with healthcare professionals to deliver integrated campaigns that not only increase patient engagement but also elevate the standard of care across the healthcare landscape. Its work bridges marketing innovation and healthcare expertise to create real impact.
  • CHALK: An experiential marketing agency that transforms bold ideas into unforgettable, immersive experiences. CHALK’s team of event architects specializes in designing events that break boundaries — from brand activations and pop-ups to major corporate experiences — creating lasting emotional connections between brands and audiences.
  • ONAR Labs: The company’s pioneering technology incubator, ONAR Labs, brings together data scientists, engineers, and industry experts to develop proprietary marketing technologies. Every product is rigorously battle-tested within the agency network before commercialization, ensuring that ONAR Labs delivers real-world solutions that enhance marketing performance and client success.

Market Opportunity

ONAR operates at the intersection of marketing services and marketing technology, two sectors undergoing rapid evolution and expansion. The global digital marketing software market alone is projected to reach $264.15 billion by 2030, expanding at a CAGR of 19.4%, according to Grand View Research. Meanwhile, healthcare marketing and experiential marketing are experiencing renewed momentum, as companies seek to create more personalized and immersive customer experiences.

With its integrated, AI-driven platform and expertise across multiple high-growth verticals, ONAR is well positioned to capture a growing share of the marketing spend from mid-sized to large enterprise clients. As businesses increasingly prioritize digital transformation, customer experience, and data-driven marketing, ONAR’s diversified offerings and proprietary technologies through ONAR Labs create meaningful competitive advantages in a highly fragmented market.

Leadership Team

Claude Zdanow, Chief Executive Officer, is a seasoned entrepreneur and business leader with deep experience scaling service organizations and technology platforms. Prior to founding ONAR, he built and successfully exited multiple companies in marketing and media, combining creative vision with operational discipline to drive measurable client growth.

Chris Becker, President, brings extensive operational and strategic expertise to ONAR, focusing on driving agency performance and expanding the company’s integrated service offering. His leadership emphasizes operational rigor, client success, and scaling the company’s footprint across industries and regions.

Patricia Kaelin, Chief Financial Officer, oversees ONAR’s financial operations and strategic planning. A distinguished financial executive with more than 25 years of experience in scaling high-growth companies and leading finance teams at both public and private companies, she expertly manages financial strategy, M&A transactions, and provides a strong foundation for ONAR’s continued expansion and acquisition initiatives.

Sam Mendez, Chief of Staff, fosters seamless collaboration across the organization. She expertly manages strategic projects, facilitates clear communication channels, and acts as a key point of contact to maximize the executive team’s impact and advance organizational goals.

Investment Considerations
  • ONAR is scaling a diversified, AI-driven marketing network addressing multiple high-growth industry verticals.
  • The company is actively pursuing an acquisition-driven expansion strategy to grow its marketing agency network.
  • ONAR Labs provides a proprietary technology pipeline, offering additional revenue streams beyond traditional marketing services.
  • A strong leadership team with proven track records in business growth, financial management, and technology commercialization positions the company for long-term success.
  • ONAR’s focus on middle market and growth-stage clients aligns with sectors expected to see a sustained rise in marketing spend over the next decade.

ONAR Holding Corp. (OTCQB: ONAR), closed Wednesday's trading session at $0.065, up 44.4444%, on 32,211 volume. The average volume for the last 3 months is 23,980 and the stock's 52-week low/high is $0.03/$0.167.

Recent News

NRx Pharmaceuticals Inc. (NASDAQ: NRXP)

The QualityStocks Daily Newsletter would like to spotlight NRx Pharmaceuticals Inc. (NASDAQ: NRXP).

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is scheduled to report its first quarter 2025 financial results after the market closes on Thursday, May 15. A conference call and webcast will follow at 4:30 p.m. ET, accessible via the company's investor relations site or by dialing +1-800-717-1738 (U.S.) or +1-646-307-1865 (international).

The earnings update comes shortly after news that NRx's wholly owned subsidiary, HOPE Therapeutics, signed a definitive agreement to acquire Kadima Neuropsychiatry Institute in La Jolla, California. Kadima is a profitable clinic and leader in psychedelic and neuroplastic research, offering treatments for suicidal depression, PTSD and other CNS conditions. It is expected to serve as the model for HOPE's national clinic rollout.

To view the full press release announcing the Kadima agreement, visit https://ibn.fm/sxSUl

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders, with a particular emphasis on conditions characterized by acute suicidality. The company is leveraging its proprietary NMDA receptor modulation platform to address significant unmet medical needs in suicidal depression, bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD).

With a commitment to advancing life-saving treatments, NRx is developing novel therapeutics aimed at providing safer and more effective alternatives to current treatment options. Its lead investigational drug, NRX-101, is positioned to be the first FDA-approved oral therapy for suicidal bipolar depression. Additionally, the company is working to bring NRX-100 (intravenous ketamine) to market as an approved treatment for acute suicidal depression, a condition for which existing treatments remain limited.

By integrating cutting-edge science with a patient-focused mission, NRx aims to transform the standard of care for individuals suffering from severe psychiatric and neurological conditions.

NRx has also established HOPE Therapeutics, a subsidiary focused on delivering interventional psychiatric care through a nationwide clinic network. HOPE Therapeutics aims to become the first coordinated system of care for suicidal depression and PTSD, combining ketamine, Transcranial Magnetic Stimulation (TMS), digital therapeutics, and other precision psychiatry tools in a supervised clinical environment.

NRx is headquartered in Wilmington, Delaware. HOPE is headquartered in Miami, Florida.

Product Portfolio

NRx Pharmaceuticals’ pipeline includes multiple late-stage therapeutic candidates targeting psychiatric and neurological disorders:

  • NRX-100: A preservative free intravenous ketamine formulation under development for acute suicidal depression, backed by strong clinical trial data and Fast Track designation from the FDA.
  • NRX-101: An oral therapy with a dual mechanism targeting NMDA and 5-HT2A receptors, designed for patients with suicidal treatment-resistant bipolar depression. The drug has received Breakthrough Therapy designation from the FDA.
  • Expanded Research: The company is further evaluating NRX-101 as a potential non-opioid treatment for chronic pain and a therapy for complicated urinary tract infections.

NRx’s therapeutic pipeline is designed to address conditions with limited or no treatment options, with the potential to improve patient outcomes and expand the standard of care.

HOPE Therapeutics

HOPE Therapeutics, a wholly owned subsidiary of NRx Pharmaceuticals, is establishing a national network of psychiatrist-led clinics focused on suicidal depression and PTSD. Its care model integrates preservative-free ketamine, TMS, digital therapeutics, and supervised psychiatric support to deliver rapid, measurable outcomes.

The company is targeting more than 30 clinic acquisitions by year-end 2025. Recent agreements include the acquisition of Dura Medical and a letter of intent with Neurospa TMS, strengthening HOPE’s foundation in interventional psychiatry. In April, HOPE also secured a term sheet for strategic investment from a global medical device manufacturer.

With ketamine sales already underway under a 503B license, HOPE projects $100 million in annual revenue and profitability by year-end 2025. Positioned as a standalone care delivery company, HOPE offers NRx a potential future spinout opportunity to unlock additional shareholder value.

Market Opportunity

The need for innovative treatments in mental health and pain management is substantial. Suicide is a leading cause of death in the United States, claiming nearly 50,000 lives each year, with over 12 million adults seriously considering suicide annually, according to the CDC.

Suicidal depression, a distinct and life-threatening condition, affects approximately 3.5 million Americans. Despite this prevalence, the only approved intervention remains electroconvulsive therapy (ECT), a treatment with significant side effects and limited access. NRx aims to address this urgent gap with NRX-100, a preservative-free intravenous ketamine formulation being developed as the first FDA-approved treatment specifically for suicidal depression.

Additionally, approximately 7 million Americans suffer from bipolar depression, a condition where nearly half of patients will attempt suicide during their lifetime and one in five may die by suicide. NRX-101, NRx’s oral drug candidate, targets this critical unmet need as a potential first-in-class therapy specifically for bipolar depression.

Beyond mood disorders, chronic pain affects over 50 million individuals in the U.S., and PTSD impacts more than 12 million people—conditions for which few non-opioid, fast-acting treatments are available. By addressing these high-risk, underserved populations, NRx Pharmaceuticals is positioned to enter multiple billion-dollar markets and reshape the standard of care for severe psychiatric and neurological illnesses.

Leadership Team

Jonathan C. Javitt, Founder, Chairman & Chief Executive Officer or NRx, and Co-CEO of HOPE, brings four decades of experience in pharmaceutical and medical device development. He has led blockbuster drug and device programs at major companies, including Allergan, Merck, and Novartis, and has served as an advisor to four U.S. presidential administrations.

Michael Abrams, Chief Financial Officer, has nearly 30 years of experience in finance, having served in executive roles, including CFO positions at Arch Therapeutics and FitLife Brands. His expertise spans investment banking, corporate finance, and business strategy.

Rick Panicucci, Chief Technology Officer, has more than 25 years of leadership in pharmaceutical manufacturing and process development. He has held key positions at Novartis, WuXi AppTec, and other major companies, leading multiple approved New Drug Applications.

Matthew Duffy, Chief Business Officer, NRx, Co-CEO of HOPE, has over 35 years of experience in biotechnology business development and investment banking. He has held leadership roles at Pfizer, MedImmune, and several financial institutions, specializing in corporate strategy and partnerships.

Investment Considerations
  • NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting significant unmet needs in central nervous system disorders.
  • The company’s lead candidate, NRX-101, has received FDA Breakthrough Therapy designation, expediting its development.
  • NRX-100 (preservative free IV ketamine) has been granted Fast Track designation by the FDA for acute suicidal depression a patent for this novel formulation has been filed with the US Patent and Trademark Office.
  • HOPE Therapeutics, NRx’s interventional psychiatry subsidiary, is targeting $100M in revenue by year-end 2025 through a national clinic network treating suicidal depression and PTSD.
  • The company’s experienced leadership team has a proven track record in pharmaceutical development and commercialization.
  • NRx is positioned to address large and growing markets with its novel depression treatments, non-opioid therapeutic solutions and directly help patients in HOPE clinics.

NRx Pharmaceuticals Inc. (NASDAQ: NRXP), closed Wednesday's trading session at $2.27, off by 0.8733624%, on 542 volume. The average volume for the last 3 months is 177,516 and the stock's 52-week low/high is $1.1/$6.01.

Recent News

Massimo Group (NASDAQ: MAMO)

The QualityStocks Daily Newsletter would like to spotlight Massimo Group (NASDAQ: MAMO).

New online platform enables national reach with end-to-end purchasing and financing

Management anticipates higher sales volume and deeper market penetration in 2025

Powersports industry demand remains strong, supported by outdoor recreation and rural mobility trends

Massimo (NASDAQ: MAMO) is entering a new growth phase with the launch of a comprehensive digital retail platform. This move, announced in April 2025, is designed to simplify the purchasing process for its UTVs, ATVs, and mini-bikes, while expanding the company's national sales footprint.

Massimo Group (NASDAQ: MAMO) is a prominent manufacturer and distributor specializing in powersports vehicles and recreational watercraft. Established in 2009, the company has built a reputation for delivering value-packed utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), and on-road vehicles to both recreational enthusiasts and professionals in the agricultural sector. In 2020, Massimo expanded its offerings by launching Massimo Marine, dedicated to crafting high-quality watercraft with advanced designs and exceptional customer service.

Massimo Group is focused on sustainability. Its recent initiatives, including the introduction of the MVR Series of electric carts, highlight the company’s commitment to eco-friendly solutions that address growing consumer demand for sustainability in the powersports and marine industries.

The company’s manufacturing capabilities have also evolved significantly. Its expanded 376,000-square-foot facility in Garland, Texas, now features advanced automation, including a vehicle assembly robot line. This addition is expected to significantly enhanced production capacity and efficiency, enabling Massimo to scale its operations and better meet market demand.

Product Portfolio

Massimo Group’s product portfolio showcases its dedication to innovation and versatility. Its diverse lineup combines advanced features, sustainability, and value to meet the needs of a dynamic market.

  • Massimo Motor: This category includes a wide range of UTVs, ATVs, go-karts, and mini-bikes designed for both recreational and practical applications. Notable recent additions include the T-Boss 1000 UTV, which combines rugged performance with advanced features, and the GKD 350 All-Terrain Go-Kart, a versatile two-seater ideal for various terrains. The Buck 550-6 Crew, a six-seater UTV, further expands this lineup, providing comfort and utility for families and light-duty users at an accessible price point.
  • Massimo Marine: Specializing in pontoon and tritoon boats, this division emphasizes luxury and performance. A recent collaboration between Massimo and Vision Marine Technologies has introduced electric pontoon platforms, catering to consumers seeking eco-friendly watercraft for both commercial and recreational use.
  • Massimo Electric: Reflecting the company’s commitment to sustainability, Massimo Electric focuses on low-speed electric vehicles (LSVs) tailored for diverse applications. Recent launches include the MVR 2X Golf Cart and MVR Cargo Max Utility Cart, which deliver advanced features and versatility for recreational users and professionals in industries like farming and groundskeeping.

By combining practicality with cutting-edge design, Massimo Group seeks to set the standard in the powersports and marine industries.

Market Opportunity

The global ATV and UTV market is experiencing robust growth, with North America projected to reach approximately $9.18 billion in 2024 and expand at a compound annual growth rate (CAGR) of 7.8% to $13.37 billion by 2029, according to Mordor Intelligence. Likewise, the U.S. electric UTV and ATV powertrain market is rapidly expanding. It was valued at $2.46 billion in 2022 and is expected to grow at a CAGR of 10.2%, reaching $5.18 billion by 2030, as reported by Grand View Research.

The pontoon boat market complements this growth, driven by increased interest in leisure and marine tourism. The market size exceeded $7.9 billion in 2022 and is projected to grow at a CAGR of 8.3% through 2032, according to Global Market Insights. Massimo Marine’s introduction of electric pontoon platforms through its Vision Marine partnership is expected to position the company to effectively address this growing market segment.

With strategic partnerships and an expanding dealer network, Massimo believes it is poised to penetrate deeper into domestic and international markets. The company’s service coverage currently includes over 2,800 retail locations, 600 motor service centers, and 5,500 marine service centers, ensuring robust support and accessibility for customers. This extensive distribution network underpins Massimo’s ability to capture market share and drive sustained growth.

Leadership Team

David Shan, Founder, Chairman, and CEO, established Massimo Motor in 2009 and Massimo Marine in 2020. He has led the company through significant growth phases, including the development of diverse product lines and its public listing. Shan holds a bachelor’s degree in international trade from Qingdao Ocean University of China.

Dr. Yunhao Chen, CPA, serves as the company’s Chief Financial Officer, bringing extensive experience in capital markets, financial reporting, and corporate governance since her appointment in May 2023. She holds a Ph.D. in Accounting and an MBA in Finance from the University of Minnesota.

Michael Smith, Vice President, joined Massimo in 2019 and played a pivotal role in launching Massimo Marine. With a strong background in powersports retail and product innovation, he is dedicated to driving new product development. Smith studied International Business and Marketing at the University of California, San Diego.

Investment Considerations
  • Massimo Group operates within a large and growing total addressable market that’s projected to surpass $18 billion by 2026.
  • The company’s cost-competitive and feature-rich products, including all-electric offerings, provide a strong value proposition.
  • Recent automation initiatives at its Texas factory are expected to improve manufacturing efficiency by an estimated 50%.
  • During the first three quarters of 2024, revenue increased by 20.8% to $91.2 million compared to the same period in 2023, reflecting strong market demand and successful product launches.
  • Strategic partnerships, such as those with Vision Marine and Rural King, enhance Massimo’s market reach and growth opportunities.
  • Consistent innovation, as seen in the launches of the T-Boss 1000 and MVR Series, is expected to drive Massimo’s push to be a leader in its industry.

Massimo Group (NASDAQ: MAMO), closed Wednesday's trading session at $2.215, off by 5.3419%, on 1,050 volume. The average volume for the last 3 months is 14,404 and the stock's 52-week low/high is $2.1601/$4.6599.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

A viral video on social media platform TikTok is popularizing a quick and easy hand test that can reportedly reveal if someone has an undiagnosed brain tumor. The British medic who demonstrated the 30-second test on the TikTok account claims that it can help individuals identify serious brain health issues that haven't been diagnosed yet. In a video clip that has since been viewed nearly 200,000 times, the user dubbed ‘Medifectious' on TikTok demonstrated how to conduct the simple test using your hands to detect potential brain tumors. According to the doctor, the process involves placing your hands together, with the bottom hand palm up and the top hand palm down on top of it. An early brain cancer diagnosis significantly improves treatment options and long-term survival rates. If someone struggles with this coordination test, it may be a sign of a deeper neurological issue, and seeking prompt medical evaluation is strongly recommended. Catching such symptoms early could make a life-saving difference. With companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) heavily investing in developing viable alternatives to the existing brain cancer treatments, the growing public awareness about how to catch these diseases early provides opportunities for treatment to be started early and increase success odds.

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company focused on brain and central nervous system cancers, has priced a "reasonable best efforts" public offering with a single healthcare-focused institutional investor, raising approximately $5 million in gross proceeds. The offering includes 3,952,570 shares of common stock at $1.265 per share and accompanying Series F warrants to purchase an equal number of shares at $1.14 per share, exercisable immediately and valid for five years. A.G.P./Alliance Global Partners is acting as the sole placement agent. Proceeds will be used for working capital and general corporate purposes. Closing is expected on or about May 14, 2025.

To view the full press release, visit https://ibn.fm/olurM

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Wednesday's trading session at $1.15, off by 15.4412%, on 33,277 volume. The average volume for the last 3 months is 3,806,658 and the stock's 52-week low/high is $0.7715/$800.

Recent News

Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG)

The QualityStocks Daily Newsletter would like to spotlight Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG).

The nickel mining industry in Indonesia has reacted negatively to the government's increase of mining royalties from 10% to rates that vary from 14-19%. The change took effect at the start of May. The government is looking at these increased royalties as a source of needed revenue to fund the ambitious programs initiated by President Subianto. For example, he started a program to offer free meals for pregnant mothers and children. He has also established a sovereign wealth fund for the country. The minerals targeted for royalty increases include copper, bauxite, nickel, gold, tin, among others. While the mining industry is complaining about these increased royalties, the government insists that the policy will be beneficial to the country and could even make the mining industry more sustainable. The government remains optimistic that the higher royalties could have the effect of reducing nickel production, which could in turn reduce the glut on the market and therefore shore up prices. For companies like Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) with planned mining operations expected to yield nickel as a by-product of gold production, the developments in Indonesia could be of interest since they may have an impact on the global market for various minerals.

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is the operator of the Waterberg Project, a bulk underground platinum group metals (PGM) deposit discovered by Platinum Group in 2011 and located on the Northern Limb of the Bushveld Complex in South Africa. The Waterberg Project is planned as a fully mechanised platinum, palladium, rhodium and gold mine, including by-product copper and nickel production, and is projected to be one of the largest and lowest cost PGM mines globally.

The project is a joint venture between Platinum Group; integrated PGM producer Impala Platinum Holdings Ltd. (OTCQX: IMPUY); Japanese consortium HJ Platinum, which includes trading house Hanwa Co. and the government-backed Japan Organization for Metals and Energy Security (JOGMEC); and local empowerment partner Mnombo Wethu Consultants (Pty) Ltd. Platinum Group has an effective 50.22% interest in the Waterberg Project.

The company’s primary business objective is to advance the Waterberg Project to a development and construction decision. An update to the 2019 Definite Feasibility Study is expected in 2024.

PGMs are essential and precious metals that include platinum, palladium, rhodium, iridium, osmium and ruthenium. These metals are known for their purity, high melting points and unique catalytic properties. They are utilized in a number of industrial processes, technologies and commercial applications and play a critical role in autocatalysis and pollution control in the automotive sector. The bulk of global PGMs are mined in Southern Africa and Russia.

The unique properties of PGMs are being applied to various technologies as possible solutions for more efficient energy generation and storage, which may create new demand for PGMs. The company’s battery technology initiative through Lion Battery Technologies Inc., using platinum and palladium in lithium battery technologies, represents one such new opportunity in the high-profile lithium battery research and innovation field.

Platinum Group Metals Ltd. founded Lion Battery Technologies Inc. in partnership with Anglo American Platinum Ltd. (AMS: JNB) to support the use of palladium and platinum in lithium battery applications. Lion Battery has entered into an agreement with Florida International University to further advance a research program that uses platinum and palladium to unlock the potential of Lithium Sulfur (Li-S) battery chemistries.

Platinum Group is headquartered in Vancouver, B.C., and Johannesburg, South Africa.

Waterberg Project

Platinum Group’s sole material mineral property, the Waterberg Project, is presently in process with pre-construction permitting; engineering work, including road upgrade and traffic studies; finalization of power and water infrastructure design; and construction camp design.

The company’s principal product from the Waterberg Project is planned to be a PGM-bearing concentrate. The concentrate will contain economic amounts of six elements comprising platinum, palladium, rhodium, gold, copper and nickel. The company’s partner in the Waterberg Project, Impala Platinum Holdings, has acquired a right of first refusal to enter into an offtake agreement, on commercial arm’s-length terms, for the smelting and refining of mineral products from the Waterberg Project.

The Waterberg project has proven and estimated reserves of 19.5 million ounces of PGMs and gold. When fully operational, the mine is projected to produce more than 400,000 ounces of PGMs annually during the peak period of steady state production. The life of the mine is projected at 45 years.

South Africa’s PGM mining sector remains closely tied to economic developments in the global automotive industry, which in 2022 accounted for approximately 43% of the total global demand for platinum and 82% of the total global demand for palladium.

Market Opportunity

According to a report from Straits Research, a global market and business research firm, the worldwide platinum market had an estimated value of $7.72 billion in 2022 and is projected to reach $11.95 billion by 2031. That represents a CAGR of 5.13% over the forecast period.

Platinum, one of the rarest of precious metals, is about 30 times scarcer than gold. It is crucial to the automotive and electronics industries and is also used to make jewelry. Stricter emissions regulations around the world have led to an increased demand for platinum to be used in catalytic converters to reduce automotive emission, the report states.

A report from Allied Market Research estimated the global palladium market at $16.3 billion in 2021 and projects the market will reach $28.6 billion by 2031, growing at a CAGR of 5.8% over the period.

Palladium is also used in automotive catalytic converters for reducing emissions and in jewelry, dentistry, watchmaking, blood sugar test strips, aircraft spark plugs, surgical instruments, electrical contacts and musical instruments.

An increase in demand for consumer electronics has driven demand for palladium-based multilayer ceramic capacitors (MLCC) used to store energy in electronic devices such as broadcasting equipment, mobile telephones, computers, electronic lighting and high voltage circuits, according to the report.

Management Team

Frank R. Hallam is Co-Founder, Director, President and CEO of Platinum Group. He has over 30 years of experience in the mining, minerals and petroleum industry as an operator, principal and founder. He was a co-founder and former CFO of MAG Silver Corp. He was also co-founder and director of West Timmins Mining Inc. and a director of Lake Shore Gold Corp. In addition, he was CFO and director with gold exploration company Tan Range Exploration Corp. He is a Chartered Professional Accountant and was formerly an auditor in the public mining practice of PwC. He holds a Bachelor of Business Administration from Simon Fraser University.

Greg Blair is CFO of Platinum Group. He has been with Platinum Group since 2010 in various roles, most recently as Interim CFO. Prior to joining Platinum Group, he was at a public accounting firm working on public company (mainly mining) audits. He is a Chartered Professional Accountant and holds a degree in Economics from Simon Fraser University and has completed the Canadian Securities Course.

Kris Begic is VP Corporate Development of Platinum Group. He has over 25 years of experience in the mining industry and capital markets and has been involved with the raising of over $500 million for various exploration and development projects globally. His efforts are focused on project generation, mergers and acquisitions, capital markets, investor relations and marketing.

Platinum Group Metals Ltd. (NYSE American: PLG), closed Wednesday's trading session at $1.12, off by 5.0847%, on 144 volume. The average volume for the last 3 months is 650,007 and the stock's 52-week low/high is $0.99/$2.27.

Recent News

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)

The QualityStocks Daily Newsletter would like to spotlight ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).

ESGold (CSE: ESAU) (OTCQB: ESAUF) President Brad Kitchen appeared on the latest episode of The MiningNewsWire Podcast to discuss the company's fully permitted Montauban project and near-term path to gold and silver production. Kitchen emphasized ESGold's unique model of funding exploration through early-stage tailings production, citing an estimated $100 million in recoverable material from the historic mine. He also highlighted the project's community impact, operational goals for 2025, and a tightly aligned marketing plan to increase visibility as production ramps.

To view the full press release, visit https://ibn.fm/1qrus

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is a fully permitted, pre-production resource company on a clear path to near-term gold and silver production. With established infrastructure in place and a significant gold-silver resource, the company is uniquely positioned to generate near-term cash flow while unlocking the full potential of its Montauban Gold-Silver Project in Quebec—one of the top mining jurisdictions in the world.

ESGold is building a foundation for long-term growth through a dual-track strategy: cash-flow generation from tailings reprocessing to fund district-scale exploration.

The Montauban site, which operated as a mine for over 80 years, is now undergoing its first-ever systematic exploration program to determine just how large the remaining deposit may be. Near-term cash flow from tailings reprocessing will be used to fund exploration, with the goal of increasing the resource base and uncovering new discoveries across the expansive land package.

ESGold is advancing a scalable and replicable clean extraction model that turns legacy mine sites into revenue generating assets while setting a new industry benchmark for sustainable resource recovery.

The recent completion of a C$3.4M financing has enabled ESGold to initiate the final construction phase of its mill circuit—moving the company decisively toward production of gold and silver in Q3 2025.

Montauban Gold-Silver Project: Production Imminent

Located approximately 80 kilometers west of Quebec City, the Montauban Project is a past-producing gold-silver mine with surface and underground mineralization and over 900,000 tonnes of historical tailings. ESGold has invested over C$15 million to date, building out roads, power access, and a 16,000 sq. ft. processing facility. The company recently completed a C$3.4M financing to begin final construction of the mill circuit.

The company is fully permitted to enter into production that is expected to commence in Q3 2025 with a capacity of 500 tonnes per day, scaling to 1,000 tpd. An updated Preliminary Economic Assessment (PEA) is currently underway to reflect all-time high gold prices and the anticipated upside from the near-surface resource.

Parallels Between Broken Hill & Montauban

Broken Hill, discovered in 1883 in Australia, became the world’s largest source of silver, lead, and zinc—producing over $100 billion worth of metals. What made it unique was that the richest mineral zones were hidden deep underground in a twisted, boomerang-like shape, and it took decades to fully understand just how large the deposit really was.

Geologists now believe ESGold’s Montauban Project in Quebec may share similar traits. Like Broken Hill, it contains high-grade silver, lead, and zinc, along with gold—and sits within the same type of geological system known to host large, high-value mineral deposits. The rock formations, mineral assemblages, and structural complexity all suggest that Montauban could be hiding much more than what’s been historically uncovered. Academic studies now support this possible geological parallel, pointing to further evidence suggesting Montauban was formed under similar conditions as Broken Hill.

Exploration Upside

With production on the horizon, ESGold is advancing a major exploration campaign. Montauban has never undergone systematic modern exploration.

The company is currently completing a large-scale Ambient Noise Tomography (ANT) survey—a powerful 3D imaging technology that will define the size, shape, and continuity of the mineralized system. ANT is already showing strong results, with imaging going beyond the original 400m depth target and now expected to exceed 800m. This cutting-edge technology has the potential to reveal the full extent of the anomaly for the first time in Montauban’s 110-year history.

Scalable, Replicable, Clean Mining

Montauban is also part of a broader vision. Across Canada and globally, there are hundreds of orphaned or legacy mine sites that remain unrehabilitated despite containing valuable residual metals in tailings. Quebec alone is home to more than 259 of these sites, highlighting the scale of the opportunity. ESGold is advancing a scalable and replicable clean extraction model that transforms legacy sites into productive assets while setting a new benchmark for sustainable resource recovery.

The company has also performed testing that utilizes Dundee Sustainable Technologies’ CLEVR Process™, a proprietary non-cyanide extraction method that achieved 90.9% gold recovery in lab testing. This clean processing approach remains a valuable and scalable asset supporting ESGold’s near-term production and exploration growth strategy.

As a complement to its core mining operations, ESGold is developing clean technology solutions through a joint venture with DMCMS Inc. This initiative includes a polymer division that manufactures environmentally friendly products such as road stabilizers, dust suppressants, and other industrial blends—expanding the company’s sustainable commercial footprint.

Market Opportunity

ESGold is operating in a unique and specialized segment of the mining industry—reprocessing and revitalizing legacy mine sites. The Montauban Project offers both near-term cash flow and long-term growth potential by converting tailings into revenue while systematically exploring for additional high-value mineral endowments. The company’s established infrastructure, full permitting, and reclamation approvals reduce development risk and enhance execution timelines.

The broader green mining market is projected to reach $15.92 billion by 2030, according to Grand View Research. This growth is being driven by increased demand for responsible extraction methods, ESG-aligned practices, and critical mineral security. With construction underway at its fully permitted Montauban site—and exploration advancing along a Broken Hill-type geological model—ESGold is well positioned to emerge as Canada’s next premier gold and silver producer.

Leadership Team

Paul Mastantuono, Chief Executive Officer and Director, graduated with distinction from the University of Ottawa with a bachelor’s degree in social science, concentrating in criminology. He has extensive experience in the construction and transportation industries and has worked as an independent business consultant for various companies, including DNA Precious Metals Inc.

Brad Kitchen, President and Director, brings over 35 years of experience in investment banking and senior corporate management, primarily with resource-based companies. He has a detailed knowledge of regulatory, security, and tax issues, cross-border financings, and market influences, which he has applied to address business challenges for issuers and investors. Mr. Kitchen was also CEO of Eagle Hill Exploration, the company that generated in only five years the first Bankable Feasibility Study on the Windfall Lake Gold Project that was recently sold by Osisko Mining to Gold Fields for US$1.6 billion.

Andre Gautier, Senior Geologist and Director, brings over 47 years of experience in the Mining Exploration field and has worked in over 35 countries. His work experience includes entities such as: SOQUEM, Falconbridge Ltd., Noramco and Cambior Inc. Mr. Gauthier was president of MaxyGold Corp. (China), INCA Pacific Resources Inc., Lara Exploration Ltd., and Gold Holding Ltd. Mr. Gauthier also served as a Director of Vena Resources Inc., MaxyGold Corp., Lara Exploration Ltd., Western Union Peru, and Gold Holding Ltd., and from March 2015 until 2018, he served as interim Managing Director and CEO of Gold Holding Ltd., headquartered in Dubai (UAE). He has a BSC in Geology Eng. and MSC from UQAC (Chicoutimi, Quebec) and is an active member and leader of many mining and professional organizations (Canada, Peru, UAE, and China).

Investment Considerations
  • Fully Permitted & Funded for Near-Term Production: Construction underway soon at Montauban with gold-silver production expected in Q3 2025.
  • Tailings-to-Cashflow Strategy: Near-term cash flow from processing historic tailings will fund exploration across the district-scale land package.
  • Replicable Clean Mining Model: Scalable approach to legacy mine redevelopment in Canada and globally.
  • Broken Hill Analogue: Geological and structural parallels suggest Montauban may host a larger, mineralized system at depth.
  • Modern 3D Imaging Tech: Cutting-edge ANT survey is producing subsurface imaging beyond 800m, uncovering the potential size of the deposit.

ESGold Corp. (OTCQB: ESAUF), closed Wednesday's trading session at $0.344, off by 4.4444%, on 39,500 volume. The average volume for the last 3 months is 120,810 and the stock's 52-week low/high is $0.0221/$0.5.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

When most people think about electric cars, China isn't the first name that comes to mind, but maybe it should be. Toyota has just sounded the alarm, and it's not just about electric vehicles anymore. According to the company, China's rise in the auto world is happening fast and across more than one area. Let's start with electric vehicles (EVs). Last year, over 17 million EVs were sold worldwide, and guess what? China sold more than 11 million of those. That's more than 60% of the global market! Even though car makers like Volkswagen, Hyundai, and Kia are coming up with new models, China is still way ahead of the game. But while China is moving full speed ahead, some countries like the U.S. are putting up trade barriers and considering cutting EV incentives. Moves like that could make it even harder for other nations to compete. In the end, it looks like China is not just shaping the future of cars, but leading it. Toyota sees what's happening and is waving a red flag. If other automakers don't speed up, they might find themselves permanently stuck in the rearview mirror. For EV companies like Mullen Automotive Inc. (NASDAQ: MULN) that are looking to claim a bigger share of the BEV market around the world, the warning on China's growing dominance issued by Toyota provides plenty of food for thought on strategy and production scaling.

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $0.165, off by 2.2512%, on 506,014 volume. The average volume for the last 3 months is 10,062,387 and the stock's 52-week low/high is $0.151/$3794220.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Wednesday's trading session at $11.08, up 3.2619%, on 1,080,083 volume. The average volume for the last 3 months is 44,399,951 and the stock's 52-week low/high is $0.7505/$11.95.

Recent News

SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN)

The QualityStocks Daily Newsletter would like to spotlight SolarBank Corp. (Cboe CA: SUNN) (FSE: GY2) (NASDAQ: SUUN).

SolarBank Corporation (NASDAQ: SUUN) (CSE: SUNN) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the United States. The company is committed to advancing the transition to sustainable energy by offering end-to-end services that include project origination, financing structuring, engineering, procurement, construction, and long-term operations and maintenance. SolarBank focuses on delivering innovative energy solutions through solar photovoltaic systems, battery energy storage systems (BESS), and electric vehicle (EV) charging infrastructure.

With a vision to provide scalable and reliable clean energy solutions, SolarBank has established itself as a leader in the renewable energy market by cultivating partnerships with utilities, commercial and industrial entities, municipalities, and residential customers. Its vertically integrated business model allows for optimized efficiency, cost management, and returns across diverse markets in North America. This end-to-end approach ensures greater control over project quality, costs, and operational outcomes, strengthening its competitive position.

Driven by a mission to create a greener future, SolarBank manages a robust portfolio of projects, including more than 100 megawatts (MW) of developed capacity and a pipeline exceeding one gigawatt (GW). The company’s commitment to sustainability and innovation makes it a recognized player in the renewable energy sector.

SolarBank has offices in Toronto, Ontario and New York.

Projects

SolarBank boasts an impressive and diverse portfolio of renewable energy initiatives that underline its leadership in the clean energy space. In the U.S., the company has over 250 MW of solar projects under development, principally in New York, focusing on community solar farms and commercial and industrial installations. Notably, SolarBank is developing several community solar projects in upstate New York, which will deliver clean energy to local residents and small businesses. Community solar projects, which are a cornerstone of SolarBank’s portfolio, provide scalable solutions for renters, homeowners, and small businesses to access affordable renewable energy, driving localized energy independence and economic savings.

In Canada, SolarBank has been a significant participant in Ontario’s Feed-in-Tariff program, where it has secured contracts for close to 200 MW of capacity. Its current management includes 70 solar power projects, totaling 28.8 MW of operational solar assets. The company’s expertise extends to the development and ownership of battery energy storage systems and EV charging stations, further diversifying its portfolio.

The company’s vertically integrated approach spans the entire project lifecycle, from initial site acquisition and grid interconnection to long-term operation and maintenance services. This ensures seamless execution and high-quality outcomes, providing value to stakeholders and supporting the transition to a clean energy future.

Market Opportunity

SolarBank operates within a growing renewable energy market driven by global demand for sustainable power solutions. In North America, favorable policies such as the Inflation Reduction Act in the United States and Canada’s investments in green technologies provide a robust foundation for renewable energy adoption. Solar PV installations and battery energy storage systems are at the forefront of this expansion, addressing energy reliability and grid stability while reducing carbon emissions.

The North American solar PV market was valued at $25.02 billion in 2019 and is projected to reach $120.74 billion by 2027, growing at a compound annual growth rate (CAGR) of 21.7% from 2020 to 2027. Likewise, the global BESS market is expected to expand from $7.8 billion in 2024 to $25.6 billion by 2029, at a CAGR of 26.9%, as reported by MarketsandMarkets. These trends are driven by the increasing integration of renewable energy sources, the need for grid resilience, and declining technology costs.

SolarBank’s operations have it well-positioned to capitalize on these opportunities. With a development pipeline exceeding one gigawatt (GW), the company is focused on meeting growing demand in community and commercial solar sectors. Decentralized energy solutions, such as virtual net metering and behind-the-meter systems, further enhance SolarBank’s market potential by addressing the critical need for flexible, cost-effective, and sustainable energy infrastructure. By leveraging its vertically integrated model and diversified portfolio, SolarBank stands as a key player in driving the renewable energy transition.

Leadership Team

Dr. Richard Lu, MD, MSc., MHSc., MBA, serves as President and CEO of SolarBank, bringing over 25 years of global energy experience. His leadership has been instrumental in advancing the company’s strategic initiatives across North America, Europe, and Asia, with a focus on renewable energy development and operational excellence.

Sam Sun, MBA, is the Chief Financial Officer of SolarBank. A Chartered Professional Accountant with more than 15 years of expertise in corporate finance, Mr. Sun has overseen financial strategies and internal controls across the cleantech, manufacturing, and mining sectors in Canada, the U.S., and China.

Andrew van Doorn, PE, serves as Chief Operating Officer, with nearly three decades of experience in engineering and construction. Mr. van Doorn has successfully led projects totaling over 200 MW of solar capacity and is a former Chairman of the Canadian Solar Industries Association.

Tracy Zheng, MBA, Chief Development Officer, has over 25 years of experience in brand marketing, business development, and solar project operations. She has spearheaded sales initiatives, conducted feasibility studies, and negotiated key partnerships that drive SolarBank’s growth.

Matt Wayrynen, Executive Chairman and Director, has a background in resource company management, venture capital, and mergers and acquisitions. Under his leadership, Solar Flow-Through Funds, where Mr. Wayrynen acted as CEO, was acquired by SolarBank, enhancing its asset portfolio and growth prospects.


Forward Looking Statements

This report contains forward-looking statements and forward-looking information ‎within the meaning of Canadian securities legislation (collectively, “forward-looking ‎statements”) that relate to the Company’s current expectations and views of future events. ‎Any statements that express, or involve discussions as to, expectations, beliefs, plans, ‎objectives, assumptions or future events or performance (often, but not always, through the ‎use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will ‎continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, ‎‎”projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be ‎forward-looking statements and may involve estimates, assumptions and uncertainties ‎which could cause actual results or outcomes to differ materially from those expressed in ‎such forward-looking statements. In particular and without limitation, this report ‎contains forward-looking statements pertaining to the Company’s expectations regarding its industry trends and overall market growth of the data center market; the Company’s expansion into the data center market, including its pursuit of opportunities as a developer, owner, and strategic partner in data center infrastructure; supporting the demand for high-performance, sustainable energy solutions within the sector; details of the company’s business plan including development of solar power projects, battery storage projects and EV charging projects; the completion of any contracts for, or construction of, any data center, solar power, battery storage or EV projects; the receipt of interconnection approval, permits and financing to be able to construct projects; the receipt of incentives for projects; and the size of the Company’s development pipeline. No assurance ‎can be given that these expectations will prove to be correct and such forward-looking ‎statements included in this report should not be unduly relied upon. These ‎statements speak only as of the date of this report.‎

Forward-looking statements are based on certain assumptions and analyses made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties. In making the forward looking statements included in this report, the Company has made various material assumptions, including but not limited to: obtaining the necessary regulatory approvals; that regulatory requirements will be maintained; general business and economic conditions; the Company’s ability to successfully execute its plans and intentions; the availability of financing on reasonable terms; the Company’s ability to attract and retain skilled staff; market competition; the products and services offered by the Company’s competitors; that the Company’s current good relationships with its service providers and other third parties will be maintained; and government subsidies and funding for renewable energy will continue as currently contemplated. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and the Company cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements.

Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under “Forward-‎Looking Statements” and “Risk ‎Factors” in the Company’s most recently completed Annual Information Form, and other public filings of the Company, which include: the Company may be adversely affected by volatile solar power market and industry conditions; the execution of the Company’s growth strategy depends upon the continued availability of third-party financing arrangements; the Company’s future success depends partly on its ability to expand the pipeline of its energy business in several key markets; governments may revise, reduce or eliminate incentives and policy support schemes for solar and battery storage power; general global economic conditions may have an adverse impact on our operating performance and results of operations; the Company’s project development and construction activities may not be successful; developing and operating solar projects exposes the Company to various risks; the Company faces a number of risks involving Power Purchase Agreements (“PPAs”) and project-level financing arrangements; any changes to the laws, regulations and policies that the Company is subject to may present technical, regulatory and economic barriers to the purchase and use of solar power; the markets in which the Company competes are highly competitive and evolving quickly; an anti-circumvention investigation could adversely affect the Company by potentially raising the prices of key supplies for the construction of solar power projects; foreign exchange rate fluctuations; a change in the Company’s effective tax rate can have a significant adverse impact on its business; seasonal variations in demand linked to construction cycles and weather conditions may influence the Company’s results of operations; the Company may be unable to generate sufficient cash flows or have access to external financing; the Company may incur substantial additional indebtedness in the future; the Company is subject to risks from supply chain issues; risks related to inflation; unexpected warranty expenses that may not be adequately covered by the Company’s insurance policies; if the Company is unable to attract and retain key personnel, it may not be able to compete effectively in the renewable energy market; there are a limited number of purchasers of utility-scale quantities of electricity; compliance with environmental laws and regulations can be expensive; corporate responsibility may adversely impose additional costs; the future impact of any resurgence of COVID-19 on the Company is unknown at this time; the Company has limited insurance coverage; the Company will be reliant on information technology systems and may be subject to damaging cyberattacks; the Company may become subject to litigation; there is no guarantee on how the Company will use its available funds; the Company will continue to sell securities for cash to fund operations, capital expansion, mergers and acquisitions that will dilute the current shareholders; and future dilution as a result of financings.

The Company undertakes no obligation to update or revise any ‎forward-looking statements, whether as a result of new information, future events or ‎otherwise, except as may be required by law. New factors emerge from time to time, and it ‎is not possible for the Company to predict all of them, or assess the impact of each such ‎factor or the extent to which any factor, or combination of factors, may cause results to ‎differ materially from those contained in any forward-looking statement. Any forward-‎looking statements contained in this report are expressly qualified in their entirety by ‎this cautionary statement.‎

SolarBank Corp. (NASDAQ: SUUN), closed Wednesday's trading session at $2.03, up 2.0101%, on 965 volume. The average volume for the last 3 months is 153,618 and the stock's 52-week low/high is $1.95/$6.87.

Recent News

Newton Golf Company Inc. (NASDAQ: NWTG)

The QualityStocks Daily Newsletter would like to spotlight Newton Golf Company Inc. (NASDAQ: NWTG).

Newton Golf Company Inc. (NASDAQ: NWTG), a Sacks Parente Company, is a technology-forward golf equipment manufacturer committed to enhancing player performance through innovative design. Since its founding in 2018, the company has developed a growing portfolio of premium golf products, including putters, golf shafts, grips, and related accessories. Its proprietary advancements include the First Vernier Acuity putter, patented Ultra-Low Balance Point (ULBP) technology, weight-forward Center-of-Gravity (CG) design, and ultra-light carbon fiber putter shafts.

As part of its commitment to growth in golf shaft technologies, the company expanded its manufacturing operations in April 2022, opening a dedicated facility in St. Joseph, Missouri. This move reinforced its goal of maintaining high-quality production standards while manufacturing and assembling substantially all of its products in the United States. In addition to golf clubs and accessories, Newton Golf Company is exploring expansion into golf apparel and other product categories.

The company sells its products through multiple channels, including resellers, its direct-to-consumer website, Club Champion retail stores, and distributors in the U.S., Japan, and South Korea. Future expansion may include growth through mergers, acquisitions, or the development of complementary product lines.

Newton Golf Company is headquartered in Camarillo, California.

Products

Newton Golf Company is focused on delivering high-performance golf equipment with a strong emphasis on precision engineering and cutting-edge materials. The company’s key product lines include:

  • Newton Motion Golf Shafts: Launched in November 2023, these shafts are engineered with proprietary flex profiles designed for greater distance, reduced dispersion, and optimized performance across swing speeds. The company’s DOT system eliminates traditional shaft flex definitions, making it accessible to all golfers.
  • Gravity Putters: Introduced in October 2024, these putters incorporate patented Ultra-Low Balance Point (ULBP) technology to improve stroke consistency and tighten putt dispersion. Manufactured in the U.S., they feature premium materials such as steel, aluminum, titanium alloys, and patented magnesium face plate technology.
  • Golf Grips & Accessories: The company continues to innovate in this category, providing golfers with performance-enhancing grips and accessories to complement their clubs.

All Newton Golf Company products are manufactured with strict quality control standards to ensure precision and reliability, reinforcing the brand’s reputation for premium performance.

Market Opportunity

The global golf equipment market was valued at approximately $8 billion in 2022, with the U.S. market accounting for $2.9 billion. The golf club segment dominated the industry, representing 45.7% of total market share. Increasing participation in golf, particularly among younger players and women, is driving demand for high-quality, customizable golf equipment.

Key industry trends supporting growth include:

  • The increasing popularity of premium, high-performance golf equipment among both professionals and amateurs.
  • A shift toward customization, as golfers seek tailored products that enhance performance.
  • A growing interest in golf from younger demographics, with amateur and collegiate golfers being particularly receptive to innovation.

Newton Golf Company’s emphasis on U.S.-based manufacturing provides it with a competitive edge in terms of supply chain efficiency, quality control, and sustainability, further strengthening its position in the market.

Leadership Team

Dr. Greg Campbell, Executive Chairman and Chief Executive Officer, brings nearly 40 years of experience in emerging technologies, product development, and public company leadership. He currently serves as CEO of V-Grid Energy Systems, a California-based company focused on converting agricultural waste into renewable electricity and bio-carbon. He has successfully taken two companies public and previously managed a $1.2 billion P&L as SVP & GM at Lam Research. Campbell holds a Ph.D. in Electrical and Electronics Engineering from UCLA and a BA/MA in Engineering from Cambridge University.

Ryan Stearns, Chief Financial Officer, was appointed in 2024 and oversees financial planning and corporate strategy. He brings expertise in scaling businesses and optimizing financial performance to support the company’s growth.

Investment Considerations
  • Newton Golf Company operates in a large and expanding global golf equipment market with rising demand for high-performance products.
  • The company benefits from strong gross margins and a clear pathway to profitability as it scales its operations.
  • U.S.-based manufacturing provides strict quality control, supply chain efficiency, and faster response times to market demand.
  • An omnichannel sales strategy, including retail, e-commerce, and international distribution, enhances market reach and revenue diversification.
  • Future growth opportunities include new product lines, strategic acquisitions, and continued technological advancements in golf equipment.

Newton Golf Company Inc. (NASDAQ: NWTG), closed Wednesday's trading session at $2.16, up 1.8868%, on 225,866 volume. The average volume for the last 3 months is 572,144 and the stock's 52-week low/high is $1.35/$195.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.